|Inhaled spores germinate and release
causing swelling in chest cavity. Possible blood and brain
||Fever, fatigue, and malaise,
two to 46 days; progresses to chest pain, cough, rapid
deterioration of health.
||Kills more than 85 percent of those
often within one to three days after symptoms appear.
be given before symptoms appear. Vaccine available, though not to
|Very contagious, airborne
||About 12 to 14 days after infection.
aches, vomiting, rash of small red spots that grow into larger,
painful pustules covering the body.
||Fatal in 30 percent of unvaccinated
||No treatment. U.S. has vaccine for
million people. Only a fraction of those vaccinated before 1972
|Natural, flea-borne form causes
Gravest threat is posed by aerosol, leading to pneumonic
||High fever, headache, and bloody
progresses to labored breathing, bluish-grayish skin color,
respiratory failure and death.
||If untreated, a person with
will almost always die within one to two days after symptoms
||Various antibiotics including
gentamicin. Isolate patients.
Viral Hemorrhagic Fever
|Highly infectious RNA viruses
Marburg, Lassa, and dengue fever. Spread by rodents, ticks,
||Vary from one type of HFV to the
fever, muscle aches, exhaustion, internal bleeding.
||Varies. Death rate from dengue is as
low as 1
percent. Ebola fatality rates have reached 90
||Mainly supportive therapy.
ribavirin useful in treating some viruses but not others (Ebola,
|Produces toxin that blocks nerve
inhibits muscle movement. Weapon would most likely aerosolize
||Difficulty swallowing food, mental
muscle paralysis, possible breathing failure.
||Inhalational form: Difficult to say
a handful of cases have been recorded.
||Patients with respiratory paralysis
placed on ventilator. Antitoxin given early may prevent